CL075

Item number	Size	Datasheet	Manual	SDS	Delivery time	Quantity	Price
TGM-T27034-1mg	1 mg		-		7 - 10 business days*		34.00€
TGM-T27034-1mL	1 ml		-		7 - 10 business days*		83.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: CL075 (3M002) is a selective TLR8 agonist with immunomodulatory activity, triggering... more

Close menu

Product information "CL075"

Description: CL075 (3M002) is a selective TLR8 agonist with immunomodulatory activity, triggering the MyD88-dependent signaling pathway and activating NF-kappaB and IRF7 to elicit the production of inflammatory cytokines and type I interferon (IFN). Target: NF-kappaB, TLR, MyD88. Smiles: CCCc1nc2c(N)nc3ccccc3c2s1. References: Lai CY, et al. TLR7/8 agonists activate a mild immune response in rabbits through TLR8 but not TLR7. Vaccine. 2014,32(43):5593-5599.

Keywords:	CL-075, 3M002
Supplier:	TargetMol
Supplier-Nr:	T27034

Properties

Application:	TLR8 agonist
MW:	243.33 D
Formula:	C13H13N3S

Database Information

CAS :	256922-53-9\| Matching products
KEGG ID :	K10170 \| Matching products

Handling & Safety

Storage:	+4°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "CL075"

Write a review